US FDA approves Urogen's bladder cancer drug

Signage is seen outside of FDA headquarters in White Oak, Maryland
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly
Source: X02844

The U.S. Food and Drug Administration has approved Urogen Pharma's drug to treat a type of bladder cancer, the regulator said on Thursday.

This article was produced by Reuters news agency. It has not been edited by Global South World.

Share

Share

Categories

Most popular tags